We conducted an analysis of KNSTRN expression levels in various types of cancers using the TIMER database and observed a significant upregulation of KNSTRN expression in several tumors, including bladder urothelial carcinoma, breast cancer, and cholangiocarcinoma. This evidence concerns the gene KNSTRN and bladder transitional cell carcinoma.